In particular, it has been proven that the levels of SNAP-25 and of the SNAP-25/Aβ42 ratio were increased in patients with progressive mild cognitive impairment and AD compared to cognitively normal individuals and could be used as a diagnostic tool also to predict the conversion from progressive mild cognitive impairment to AD [60]. Here, SNAP25 is linked to Alzheimer disease.